CD47 and neoplasm: developed a nanovaccine constructed using CD47 knockout (CD47KO)/calreticulin (CRT) dual‐bioengineered B16F10 tumor cell membranes and an unmethylated cytosine–phosphate–guanine (CpG) adjuvant.